Profile
Helen Hovenga is currently the Chief People Officer & Head-Human Resources at Nuchev Ltd. She previously worked as the Executive Director-People & Culture at Peter MacCallum Cancer Institute from 2018 to 2020 and as the Global Chief People Officer at Telix Pharmaceuticals Ltd. from 2021 to 2022.
Ms. Hovenga holds an MBA from Charles Sturt University and an undergraduate degree from Swinburne University of Technology.
Helen Hovenga active positions
| Companies | Position | Start |
|---|---|---|
| NUCHEV LIMITED | Human Resources Officer | 31/12/2022 |
Former positions of Helen Hovenga
| Companies | Position | End |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Human Resources Officer | 31/08/2022 |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Human Resources Officer | 30/11/2020 |
Training of Helen Hovenga
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Charles Sturt University
Charles Sturt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swinburne University of Technology
Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Government |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Nuchev Ltd.
Nuchev Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Develops, produces and sells milk based nutrition products | Consumer Non-Durables |
- Stock Market
- Insiders
- Helen Hovenga
















